Previous close | 0.0988 |
Open | 0.0988 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0920 - 0.0990 |
52-week range | 0.0300 - 0.1500 |
Volume | |
Avg. volume | 1,661,309 |
Market cap | 99.684M |
Beta (5Y monthly) | 0.33 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | 10 May 2024 - 14 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today what it considers to be a major milestone. The Company has completed rearing of the first generation of its new BAM-1 parental strains as part of its spring production trial. Kraig Labs has successfully produced cocoon at rates that exceeded all expectations and control parameters for these trials. Under the supervision and guidance of a top indepe
ANN ARBOR, Mich., April 15, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that the spring production trials for the new BAM-1 hybrid have begun and are well on track to meet the Company's expectations and timeline. The Company successfully launched the production trials of BAM-1, its newest and most robust recombinant spider silk production silkworm hybrid, on time and in line with its production roadmap. The Company's C
ANN ARBOR, Mich., April 08, 2024 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company" or "Kraig Labs"), announces today that it has signed a landmark agreement with the Vietnam Sericulture Association ("VSA"). As part of this agreement, the Company disclosed its production plans and schedule for the next twenty-four months to the VSA to obtain cooperation in reaching its production targets. This agreement establishes a collaborative working effort between the Compan